Here we demonstrate upregulation of HNF4α in PNAC and that pharmacologic antagonism of HNF4α (by BI6015) significantly reduced hepatic NFκB activation, induced hepatocyte bile and sterol transporter expression, and reduced cholestasis and hepatic injury in murine PNAC. The gene discussed is NFKB1; the disease is cholestasis.